Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 14,096 shares at $1.10 ($16K) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Seasonal sale ($16k) by CFO and Treasurer — this insider has traded JNCE in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.10 | 6,315 | $7K | 44.4% |
| 2 | $1.12 | 7,781 | $9K | 55.6% |
| Total | $1.11 avg | 14,096 | $16K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |